Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation

• Status: Unknown status
• Trial end date: 2007-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate and compare, in the single center setting, the safety, efficacy and cost-effectiveness of the two standard immunosuppressive regimens based on tacrolimus and cyclosporine.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Uniwersytet Mikolaja Kopernika w Toruniu
• Collaborator: Astellas Pharma Inc
• Treatments: Cyclosporine; Cyclosporins; Tacrolimus

Criteria

Inclusion Criteria:

• First or second cadaveric kidney transplantation

• Age over 18 years old

• Specific indications or contraindications for cyclosporine or tacrolimus are absent

• Informed consent

Exclusion Criteria:

• Specific indications for use of cyclosporine or tacrolimus

• Specific contraindications for use of cyclosporine or tacrolimus

• Participation in another interventional clinical trial

• Pregnancy or lactation